Rational synthesis of a heparan sulfate saccharide that promotes the activity of BMP2

被引:2
作者
Shaffer, Karl J. [1 ]
Smith, Raymond A. A. [2 ,3 ]
Daines, Alison M. [1 ]
Luo, Xiaoman [2 ]
Lu, Xiaohua [2 ]
Tan, Tuan Chun [2 ]
Le, Bach Q. [2 ]
Schwo, Ralf
Hinkley, Simon F. R. [1 ]
Tyler, Peter C. [1 ]
Nurcombe, Victor [4 ]
Cool, Simon M. [2 ,3 ,5 ]
机构
[1] Victoria Univ Wellington, Ferrier Res Inst, 69 Gracefield Rd, Gracefield 5010, Lower Hutt, New Zealand
[2] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore
[3] Univ Queensland, Sch Chem Engn, Brisbane, Qld 4072, Australia
[4] ASTAR, Inst Med Biol, Singapore 138632, Singapore
[5] Natl Univ Singapore, Yong Yoo Lin Sch Med, Dept Orthopaed Surg, Singapore, Singapore
关键词
Heparan sulfate; BMP-2; Rational design; Bone regeneration; SELECTION; GAMMA; ACID;
D O I
10.1016/j.carbpol.2024.121979
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Heparan sulfate (HS) is a glycosaminoglycan (GAG) found throughout nature and is involved in a wide range of functions including modulation of cell signalling via sequestration of growth factors. Current consensus is that the specificity of HS motifs for protein binding are individual for each protein. Given the structural complexity of HS the synthesis of libraries of these compounds to probe this is not trivial. Herein we present the synthesis of an HS decamer, the design of which was undertaken rationally from previously published data for HS binding to the growth factor BMP-2. The biological activity of this HS decamer was assessed in vitro, showing that it had the ability to both bind BMP-2 and increase its thermal stability as well as enhancing the bioactivity of BMP-2 in vitro in C2C12 cells. At the same time no undesired anticoagulant effect was observed. This decamer was then analysed in vivo in a rabbit model where higher bone formation, bone mineral density (BMD) and trabecular thickness were observed over an empty defect or collagen implant alone. This indicated that the HS decamer was effective in promoting bone regeneration in vivo.
引用
收藏
页数:17
相关论文
共 45 条
[1]   The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications [J].
Ayerst, Bethanie I. ;
Merry, Catherine L. R. ;
Day, Anthony J. .
PHARMACEUTICALS, 2017, 10 (02)
[2]   Syntheses of β-D-GalpNAc4SO3-(1→4)-L-IdopA2SO3, a disaccharide fragment of dermatan sulfate, and of its methyl α-L-glycoside derivative [J].
Barroca, N ;
Jacquinet, JC .
CARBOHYDRATE RESEARCH, 2000, 329 (03) :667-679
[3]   Using automated glycan assembly (AGA) for the practical synthesis of heparan sulfate oligosaccharide precursors [J].
Budhadev, Darshita ;
Saxby, Karinna ;
Walton, Julia ;
Davies, Gideon ;
Tyler, Peter C. ;
Schworer, Ralf ;
Fascione, Martin A. .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2019, 17 (07) :1817-1821
[4]   Determining the extent of heparan sulfate depolymerisation following heparin lyase treatment [J].
Carnachan, Susan M. ;
Bell, Tracey J. ;
Sims, Ian M. ;
Smith, Raymond A. A. ;
Nurcombe, Victor ;
Cool, Simon M. ;
Hinkley, Simon F. R. .
CARBOHYDRATE POLYMERS, 2016, 152 :592-597
[5]   BMP6 binding to heparin and heparan sulfate is mediated by N-terminal and C-terminal clustered basic residues [J].
Denardo, Andrea ;
Elli, Stefano ;
Federici, Stefania ;
Asperti, Michela ;
Gryzik, Magdalena ;
Ruzzenenti, Paola ;
Carmona, Fernando ;
Bergese, Paolo ;
Naggi, Annamaria ;
Arosio, Paolo ;
Poli, Maura .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2021, 1865 (02)
[6]   Order out of chaos: Assembly of ligand binding sites in heparan sulfate [J].
Esko, JD ;
Selleck, SB .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :435-471
[7]  
Gainsford Graeme J, 2013, Acta Crystallogr Sect E Struct Rep Online, V69, po259, DOI 10.1107/S1600536813000780
[8]   INTERMEDIATE STEPS IN AUTOXIDATION .4. REACTIONS OF MN(III ACETATE IN ACETIC-ACID ACID WITH METHYL BENZOATE AND WITH BENZOIC ACID(S) [J].
GORTERLAROIJ, GM ;
KOOYMAN, EC .
JOURNAL OF CATALYSIS, 1972, 25 (02) :230-+
[9]   First Gram-Scale Synthesis of a Heparin-Related Dodecasaccharide [J].
Hansen, Steen U. ;
Miller, Gavin J. ;
Jayson, Gordon C. ;
Gardiner, John M. .
ORGANIC LETTERS, 2013, 15 (01) :88-91
[10]   BONE MORPHOGENETIC PROTEIN-2 CONVERTS THE DIFFERENTIATION PATHWAY OF C2C12 MYOBLASTS INTO THE OSTEOBLAST LINEAGE [J].
KATAGIRI, T ;
YAMAGUCHI, A ;
KOMAKI, M ;
ABE, E ;
TAKAHASHI, N ;
IKEDA, T ;
ROSEN, V ;
WOZNEY, JM ;
FUJISAWASEHARA, A ;
SUDA, T .
JOURNAL OF CELL BIOLOGY, 1994, 127 (06) :1755-1766